National Coalition Formed to Protect Small-Scale Cannabis Growers

The National Craft Cannabis Coalition, comprised of state-level advocacy groups from Oregon, California, Washington, Vermont, Maine, and Massachusetts, was formed with the goal of promoting state and federal policies that support small-scale growers, starting with the SHIP Act introduced by Rep. Jared Huffman (D-CA).

The SHIP (Small and Homestead Independent Producers) Act would allow craft growers to ship and sell weed directly to their consumers if and when marijuana is federally legalized. If passed, the bill would take effect once marijuana is removed from its current Schedule 1 status and once all criminal penalties are removed under federal law concerning marijuana.

“Too often, the federal government falls behind, and the gears of Congress work too slowly to keep up with the pace of a changing economy,” Representative Huffman said.

“Under my bill, folks in our state will be able to ship their products straight to consumers when the antiquated federal prohibition on cannabis is finally repealed. As large, commercial cannabis operations squeeze out local producers from the market, this legislation is critical for farmers to survive and expand their small businesses.”

Under the SHIP act, a qualifying cannabis grower would be anyone who cultivates:

  • One acre or less of 18 mature flowering marijuana plant canopy using outdoor cultivation
  • 22,000 square feet or less of marijuana plant canopy using greenhouse cultivation
  • 5,000 square feet or fewer of mature flowering marijuana plant canopy using indoor cultivation

Small and craft growers have lamented they don’t stand a chance in markets dominated by large multi-state operators capable of growing exponentially more canopy space for a fraction of the cost, especially when the final product has to be packaged and sold through third-party businesses. This results in a lot of large, vertically-integrated companies essentially pricing out the little guys who can’t afford to buy and operate their own dispensary, grow facility, and packaging facility.

“These producers operate on a much smaller scale than traditional agriculture with many cultivating less than an acre of total canopy,” said Amanda Meztler of F.A.R.M.S. Inc Oregon.

“With federal legalization on the horizon, it’s critical that craft cannabis producers organize across state lines to ensure that federal policy includes a level playing field for small and independent businesses.”

Thus, members of the NCCC have collectively proposed that the only way small growers can survive is if they are allowed to sell directly to their customers.

“The direct-to-consumer model is a necessary resource for any small-scale craft-producing community that is deeply tied to the land on which it creates — whether it produces wine, whiskey, cheese, beer, cannabis, or honey,” said Genine Coleman, Executive Director of Origins Council in a prepared statement.

“The legacy cannabis community that has worked so long in the shadows should have the opportunity to join the ranks of other artisan producers across the United States and enjoy the privilege of connecting personally with their adult customers.”

To date the NCCC represents over 1,000 small and independent commercial cannabis growers through their state-level organizations including Origins Council (CA), F.A.R.M.S. Inc (OR), Washington Sun & Craft Growers Association (WA), Vermont Growers Association (VT), Maine Craft Cannabis Association (ME), and Farm Bug Co-Op (MA).

The post National Coalition Formed to Protect Small-Scale Cannabis Growers appeared first on High Times.

DEA Chooses Seventh Cannabis Cultivator License for Research Purposes

Maridose LLC, based in Maine, announced on Aug. 19 that it officially received a federal cultivation license from both the United States Department of Justice, as well as the Drug Enforcement Agency (DEA). The company is one of only seven in the country that have been approved by the DEA as a “bulk manufacturer marihuana grower.”

“We are very excited to receive this license from the DEA to produce and sell cannabis for research purposes, this a huge step for science and the future of cannabis,” said Maridose Founder Richard Shain.

In the past, the only institution that was legally allowed to provide cannabis to researchers was the University of Mississippi’s National Center for Development of Natural Products, when it received the country’s only cultivation registration from the DEA in 1968. That monopoly ended in May 2021 when the DEA announced that it would eventually be granting cultivation licenses to third-party applicants. “Pending final approval, DEA has determined, based on currently available information, that a number of manufacturers’ applications to cultivate marijuana for research needs in the United States appears to be consistent with applicable legal standards and relevant laws. DEA has, therefore, provided a Memorandum of Agreement (MOA) to these manufacturers as the next step in the approval process.”

Also in May 2021, the Scottsdale Research Institute in Arizona and Biopharmaceutical Research Co. in California received approval. Royal Emerald Pharmaceuticals in California, received approval in December 2021, followed by Groff North America, based in Pennsylvania, in March 2022 and California-based Irvine Labs in April 2022. And now in August, Maridose makes the seventh applicant to be approved so far.

“Our DEA Registration Number RM063095 is the culmination of over five years of working with the DEA and enables Maridose to legally sell a wide variety of cannabis products through the DEA to researchers and DEA-licensed pharmaceutical companies in the United States and internationally,” said Shain. “The DEA has indicated that it will only issue a very limited number of them, and Maridose is proud to be one of the first companies to receive a license. Cannabis businesses operating in states that have state legal cannabis are unable to ship across state lines and operate at legal risk because cannabis remains a Schedule 1 substance at the federal level. Maridose is able to legally supply our customers without these risks and limitations.”

As of Aug. 22, the Federal Register lists many applications for the coveted bulk manufacturer license.

Dr. Sue Sisley, President of the Scottsdale Research Institute, has long been respected as a leader in cannabis study. Although the institute received approval from the DEA in May 2021, it still wasn’t safe from the ongoing issue of banking in the cannabis industry. In October 2021, Sisley took to Twitter, explaining how the Bank of America closed the Scottsdale Research Institute’s accounts with very little notice. “Bank of America closes down account of Federally-licensed cannabis researcher. SRI conducts FDA approved controlled trials evaluating cannabis as medicine for treating pain/PTSD in military veterans & terminally ill patients this TRAGICALLY shuts down our research @BankofAmerica,” she wrote on Oct. 12, 2021.

The SAFE Banking Act would be a welcome improvement to ongoing cannabis industry woes, but many believe that it’s not enough to fully protect cannabis businesses.

Cannabis research continues to ramp up, with Louisiana University recently receiving approval to study cannabis. It’s currently one of only two schools that has been chosen in the state so far. In June, the government researchers spoke up about their work in helping treat military veterans with MDMA and psilocybin.

The post DEA Chooses Seventh Cannabis Cultivator License for Research Purposes appeared first on High Times.

Maine Dispensaries Anticipate Sales Onslaught Ahead of Phish Show

Dispensaries in Maine are preparing to batten down the hatches. Bangor Daily News reports that jam-band Phish is coming to town, and local dispensary workers are bracing for the frenzied rush of business the concert will likely bring.

Phish will perform at the Maine Savings Amphitheater on the Bangor Waterfront in Bangor, Maine on July 16—marking the band’s fifth performance in the city since 1993 and its 47th show in Maine. It’s the first time Phish is performing in Maine with recreational sales after the state legalized cannabis two years ago.

Why all the fuss? Because Phish’s fanbase of tie-dyed stoned hippies are so devoted and cult-like, the argument has even been made that Phish is an actual cult. (It’s not.) Unlike typical bands, Phish fans follow the band around the country religiously, and concerts generally draw a lot of outsiders—outsiders who smoke bud. Five-digit numbers of people in the crowd is not too uncommon.

While locals are wary about the influx of cannabis that is likely to happen, they also acknowledged how the pot-smoking crowd is easier to deal with than a drunk crowd.

“Phish fans definitely bring a great crowd, but they are pretty well-behaved compared to others. It’s not crazy like the country shows. Those fans like to party,” Mark Greenleaf, owner Carolina Sports & Spirits, told Bangor Daily News. Greenleaf’s business storefront is only a few hundred feet from the entrance to the amphitheater that Phish will perform at. “We’re happy to have any concert event. They always bring us some business, and many of them pack the place.”

Dispensary owners also expect an increase in sales, but maybe aren’t 100% convinced the concert will create a phenomenon.

“We’re grateful for every concert that comes to town. It’s always a boon for us,” said Sam Cross, manager at Firestorm, a dispensary in town. “It’s hard to say exactly what kind of crowd we’ll see for Phish, but we’ll definitely see them. It’s always nice to see a caravan of Phish fans come in.”

High Times reported on the phenomenon that Phish concerts create, providing an atmosphere that you don’t even need weed to enjoy. Last April 20 in New York, Phish also performed at Madison Square Garden, celebrating the state’s first legal 420 holiday.

The event in Maine may not be quite so large, but it draws the same cult-like devotion seen at the band’s other concerts.

Cannabis and psychedelics are practically synonymous with the band as they complement the musical genre very well. The Vermont-based band formed in 1983 and plays the jam-band style of music that emerged out of the 1960s psychedelic scene. When Jerry Garcia died in 1995, apparently a lot of Grateful Dead followers—aka deadheads—refocused on Phish. Expect a lot of braided hemp and glass pipe accessories, and plenty of long hair. The band consists of lead vocalist Trey Anastasio along with Page McConnell, Mike Gordon, and Jon Fishman.

Phish has played in Maine nearly 50 times since 1989. At one particular event, The Great Went at Loring Air Force Base in Aroostook County in 1997, over 75,000 people showed up. It was 1997’s highest-grossing rock concert in the U.S., according to Bangor Daily News.

The post Maine Dispensaries Anticipate Sales Onslaught Ahead of Phish Show appeared first on High Times.

Police Link Rash of New England Cannabis Facility Burglaries

Police have linked a rash of burglaries targeting New England cannabis dispensaries to a trio of suspects in Massachusetts, according to a report from the Portland Press Herald. Law enforcement officers say that a man from New Bedford, Massachusetts and two brothers from Boston are suspected in the string of burglaries of licensed cannabis enterprises going back to 2020.

Police began connecting the crimes after a burglary at a cannabis grower in Gorham, Maine in October of last year. In that caper, three individuals wearing face coverings, hats and long sleeves cut their way through an exterior wall of the business located in an industrial park while a fourth person stood watch outside. The three burglars inside the building moved cautiously from room to room, trying to avoid detection by motion sensors. When the team finally left a couple of hours later, they took 30 pounds of cannabis and 500 THC vape cartridges with them.

During their investigation, police reviewed video from the cannabis cultivator’s security cameras. One camera caught the image of the Massachusetts license plate of a pickup truck that entered the parking lot two hours before the crime. And inside the building, one of the camera’s microphones recorded the burglars talking to one another.

“Where the (expletive) is Dario?” one burglar clearly said to another.

“He’s putting the trunks in the truck, ” the accomplice replied.

Investigation Yields Three Suspects

The license plate led law enforcement officers to Dario Almeida, a 21-year-old man with an address in New Bedford, Massachusetts. When Gorham police Detective Stephen Hinkley called New Bedford police, they gave him a cellphone number for Almeida, who had had a recent contact with the department.

A week later, police in New Bedford contacted Hinkley via email to inform him that Almeida and his brother Rafael were suspects in a similar burglary of a cannabis cultivator in Warwick, Rhode Island, where the same pickup truck was also caught on video. Police believe that the brothers are from South Boston and a third suspect is from New Bedford, according to Mass Live.

After reaching out to other New England law enforcement agencies, Hinkley learned of seven similar burglaries that had occurred in Maine since June of last year. Another Gorham cannabis business was also burglarized by criminals who cut through an exterior wall on Thanksgiving night in 2020. Burglars also targeted a cannabis business in South Portland, Maine. In January, a Portland, Maine judge issued a search warrant for evidence including location data from one of the suspect’s cell phones for the times that two of the burglaries occurred. No arrests have yet been made, and the case is still being investigated.

Police in South Portland and Warwick did not reply to reporters’ questions about the burglaries. Gorham Police Chief Christopher Sanborn also declined to comment on the rash of burglaries.

“This is an open investigation that we are currently working on,” Sanborn said. “I’m sorry, but I cannot comment any further at this time.”

Maine’s cannabis regulatory agency, the Office of Marijuana Policy, requires licensed cannabis businesses to report burglaries, robberies and other crimes. But David Heidrich, a spokesperson for the agency, said that many businesses are not familiar with the procedure to submit such reports. The reports the regulator has received are confidential and an analysis of the information they contain has not been conducted by the agency.

“We are not a law enforcement entity, and our role in regulating cannabis is to ensure licensee and registrant compliance with Maine’s adult and medical use of marijuana laws,” Heidrich wrote in response to a request for information on crime reports at cannabis businesses. “Thefts and burglaries are crimes, and the best source for information about criminal activity is and has always been law enforcement.”

An executive at Tetrapoint LLC, a South Portland-based cannabis security firm that transports pot and cash for cannabis businesses, told the Portland Press Herald that many companies are lulled by Maine’s reputation as a low-crime state into being complacent about security. But he said that the threat to cannabis businesses still exists.

“The tendency is to say, the bank’s only a half-hour away, why would we pay people to drive there?” said the executive, who requested anonymity to prevent being targeted for robbery while he’s on the job. “We have clients who are next door to a bank, and they still utilize our services.”

The executive also noted that despite pot’s continued illegality at the federal level, many local police departments are treating cannabis businesses just like other crime victims.

“In several different communities, we’ve found that local law enforcement are very friendly because it’s driving new business,” the security executive said.  “Some folks may not be particularly happy about the industry, but it’s here, it’s now and it’s happening.”

The post Police Link Rash of New England Cannabis Facility Burglaries appeared first on High Times.

Maine Advocacy Group Calls For Tighter Medical Regulations

A new group, known as Protect Maine’s Cannabis Consumers, said last week that “it will work to raise public awareness about the Maine medical marijuana industry’s lack of regulations and urge the Legislature to mandate both product testing and so-called track-and-trace requirements, closing what it says is a ‘dangerous loophole,’” according to the Portland Press Herald.

The group is drawing attention to a peculiar disparity between the state’s two cannabis programs. As the Press Herald noted, while the adult-use recreational program, which debuted in 2020, requires tracking and testing, the medical cannabis program, which Maine voters legalized back in 1999, does not.

The president of the advocacy group, Kevin Kelley, said at a press conference on Friday that the inconsistent requirements between the two cannabis programs “defies common sense.”

Those concerns echo what one of the state’s top cannabis officials said last year.

Erik Gundersen, director of the Maine Office of Marijuana Policy, told Maine lawmakers in November that there was persistent illegal activity within the medical cannabis program.

As reported by the Bangor Daily News at the time, Gundersen said his office “has fewer ways to regulate the medical use market than the recreational market for which retail sales started just last year,” and that it “would be helpful if there were tools to ensure that cannabis grown in the medical program stayed within it.”

The newspaper reported that Gundersen believes “there’s more illegal activity connected to the state’s medical marijuana industry and that his office has few tools to prevent medical cannabis from finding its way to the black market.” With only 12 field investigators, Gundersen said his available resources are not “sufficient for performing the necessary level of oversight when the investigators are only getting to registrants every four to five years.”

In August, Gundersen announced the formation of the Marijuana Working Group, which was tasked with making recommendations intended to strengthen the state’s longstanding medical cannabis program.

Gundersen’s office said that the working group would be “composed of at least 16 external members who represent Maine’s medical marijuana industry, cannabis patients, public health system, and towns and cities,” who would “advise on regulatory issues, best practices in patient access and education, contribute to ongoing improvements in Maine’s medical cannabis program.”

The Office of Marijuana Policy said it was seeking “at least five registered caregivers, two registered dispensary representatives, one marijuana testing facility representative, one products manufacturing facility representative, three qualifying patients who are not also registered caregivers, two individuals representing municipalities in Maine, and two relevant health care professionals” to serve on the working group.

“We look forward to the opportunity presented by convening a group of well-qualified individuals in pursuit of a shared goal to both preserve patient access and support the regulated marketplace,” Gundersen said in a press release at the time. “Our vision as a cannabis regulator has always been to develop a good faith partnership with our stakeholders by establishing rules and policies that provide interested consumers with access to a regulated industry.”

But the calls for tougher rules and requirements have been met with resistance from some corners of Maine’s medical cannabis industry.

The Portland Press Herald noted that the industry “has pushed back against testing and tracking requirements for over a year, expressing concerns about the cost, both to the providers and their customers,” most notably a proposed track-and-trace system that cannabis business owners successfully lobbied against in the legislature.

The post Maine Advocacy Group Calls For Tighter Medical Regulations appeared first on High Times.

Maine Aims to Disallow Out-of-town Cannabis Business Owners

The state of Maine is determined to preserve its requirement that cannabis businesses be owned by its own residents, bringing the dispute into uncharted legal territory.

First, some background. Officials in the Pine Tree State “originally required all medical and recreational cannabis businesses to be owned by residents,” as the Portland Press Herald explained in an article. 

But that requirement was challenged last year by Wellness Connection of Maine, the state’s largest chain of medical cannabis dispensaries that had sought a license for a recreational cannabis dispensary in Portland, the capital city of Maine.

Wellness Connection, which is owned by a Delaware-based LLC, filed a lawsuit against the city of Portland after council members there approved an ordinance capping the number of licenses for adult pot use dispensaries and establishing a system that gave preferential treatment to local applications.

Matt Warner, an attorney for Wellness Connection, argued that the requirement was unconstitutional, saying that as “a matter of constitutional law, states and cities can’t discriminate against citizens of other states based purely on residency.”

“More than 25 percent of the points awarded through Portland’s competitive licensing process are based on residency, so we’re automatically disqualified for those points, based purely on our owner being from Delaware,” Warner said at the time.

The company argued in its filing that limiting “the opportunities for (Wellness Connection) to create a brand, build a reputation and establish customer loyalty in Portland at the adult-use market’s inception would harm them in ways that cannot be reduced to a monetary damages award.”

The state stood down, eventually doing away with the requirement for recreational cannabis businesses, and in August, a federal court sided with Wellness Connection in a ruling that overturned the in-state residency requirement for medical marijuana dispensaries. 

That decision, from U.S. District Court Judge Nancy Torresen, has set the stage for the latest round in the dispute between the state and Wellness Connection, with Maine seeking to uphold its requirement that medical dispensaries be owned by residents.

The Press Herald reported that it “appears the case is the first of its kind to reach a federal appeals court, where the opinion could have ramifications in other states,” with the central question hovering over “whether the residency rule violates the U.S. Constitution by restricting interstate commerce.”

In her ruling back in August, Torresen said that the “notion that the medical marijuana industry in Maine is wholly intrastate does not square with reality.”

“I recognize that none of the courts that have confronted this specific constitutional issue have rendered final judgments, and it also seems that no circuit court has addressed it,” the judge wrote, as quoted by the Press Herald.

“But given the Supreme Court’s and First Circuit’s unmistakable antagonism towards state laws that explicitly discriminate against nonresident economic actors, I conclude that the Dispensary Residency Requirement violates the dormant Commerce Clause.”

The appeal has been filed by both the state of Maine and a nonprofit industry group called the Maine Cannabis Coalition, which is in favor of the residency requirement.

In briefs filed in the 1st U.S. Circuit Court of Appeals, the state says that “the dormant Commerce Clause does not apply to Maine’s intrastate market for medical marijuana.”

“Nor do the residency requirements in the Maine Medical Use of Marijuana Act burden interstate commerce more severely than Congress, because Congress has already eliminated that market,” the brief said, as quoted by the Press Herald. “Because striking down Maine’s residency requirements at issue in this case would do nothing to expand legal interstate commerce in the United States, they should stand.”

The post Maine Aims to Disallow Out-of-town Cannabis Business Owners appeared first on High Times.

Maine Official Condemns Influx in Illegal Cannabis Activity

The top cannabis official in Maine sounded the alarm this week on illicit conduct tied to the state’s medical marijuana industry and illegal cannabis.

Erik Gundersen, director of the Maine Office of Marijuana Policy, made the comments to the Maine Legislature’s Marijuana Advisory Commission, which held a meeting on Tuesday.

The Bangor Daily News reported that Gundersen told the commission that “he believes there’s more illegal activity connected to the state’s medical marijuana industry and that his office has few tools to prevent medical cannabis from finding its way to the black market,” saying his office has 12 field investigators who are far from “sufficient for performing the necessary level of oversight when the investigators are only getting to registrants every four to five years.”

Gundersen noted that “the vast majority of caregivers in the medical marijuana industry are following the rules,” but that illegal activity nevertheless persists.

“It’s an economics thing. You can do quick, back-of-the-napkin math,” Gundersen said, as quoted by the Bangor Daily News. “I would imagine it’s easy to veer into the more gray area.”

Recreational and medical marijuana are both legal in Maine. It was reported that Gundersen told the legislative commission that his “office has fewer ways to regulate the medical use market than the recreational market for which retail sales started just last year.”

Voters in Maine legalized medical cannabis all the way back in 1999, and they did the same for recreational marijuana in 2016—although that law’s rollout was stymied by opposition from former Maine Gov. Paul LePage, who was staunchly opposed to legalization.

LePage vetoed legislation in 2017 that would have implemented the voter-approved law, but lawmakers in the state overturned his veto the following year.

In 2018, Maine voters elected a different governor, the Democrat Janet Mills, who moved quickly to implement the new marijuana law. Mills signed legislation in June of 2019, months after being sworn in, that helped finally implement what voters had sought years earlier.

Recreational pot sales finally began in the state in October of last year. By May, the state had racked up $5.3 million in recreational pot sales, which at the time was the highest grossing month since the market opened.

Gundersen said at the time that one of “the main goals of cannabis legalization is to diminish the illicit market.”

“The strong month-over-month growth here in Maine, just seven months after the official launch of the industry, suggests more and more consumers are choosing the tested, tracked, and well-regulated market over the illicit market,” Gundersen said then. “That is a positive sign for Mainers’ health and for the viability of the industry. With Maine’s busy summer season upon us, our effective regulation of the industry will continue.”

In August, the state doubled that total, pulling in more than $10 million in recreational pot products.

Despite those successes, Gundersen’s comments this week served as a reminder of the resilience of the illicit marijuana market, even in states and cities that have embraced legalization.

In California, for example, where voters legalized recreational pot use five years ago, “fully legal weed makes up just a fraction of the state’s marijuana market, with some experts estimating that 80 to 90 percent of cannabis sales in California still fall into a legal gray zone,” according to a report last week by National Public Radio.

Gundersen said Tuesday that it is “certainly one of the underlying objectives of a legalized market to eradicate the traditional market.”

“And that’s one of the things that I think, here in Maine, we’re struggling with,” he said, as quoted by the Bangor Daily News.

The post Maine Official Condemns Influx in Illegal Cannabis Activity appeared first on High Times.

Maine Recruiting Members of New Medical Marijuana Workgroup

Cannabis regulators in Maine are recruiting members to serve on a new workgroup tasked with advising the state on its medical marijuana program. Dubbed the Marijuana Working Group, the newly formed panel will consist of civic officials, industry representatives, caregivers, and medical marijuana patients who will make recommendations to Maine’s Office of Marijuana Policy (OMP) with the goal of improving the state’s medicinal cannabis program.

On Friday, OMP director Erik Gundersen announced the formation of the new working group in a press release from the agency.

“We look forward to the opportunity presented by convening a group of well-qualified individuals in pursuit of a shared goal to both preserve patient access and support the regulated marketplace,” said Gundersen.

Maine legalized medical marijuana in 1999, while cannabis was legalized in the state for use by adults in 2016. Governor Janet Mills created the OMP as part of the Maine Department of Administrative and Financial Services to regulate both medicinal and recreational cannabis in 2019.

Prohibitionist Need Not Apply

The Marijuana Working Group will be composed of representatives of the OMP and at least 16 volunteer external members, with all but two seats on the panel reserved for members of the medical marijuana community. Five seats are reserved for registered caregivers, and three more will be filled by qualifying medical marijuana patients. The medical marijuana industry will also be represented on the workgroup, including two seats to be filled by a registered dispensary, one by a marijuana testing facility, and another by a cannabis products manufacturer.

The working group’s membership will be rounded out by two health care professionals with a relevant area of expertise and two representatives of municipal governments. To be qualified for the panel, prospective members must have relevant experience for the seat for which they are applying. Those seeking seats reserved for industry representatives must hold an active license or registration with the OMP and be in good standing with the Maine Department of Administrative and Financial Services. 

Prospective members of the Marijuana Working Group must also not be a registered lobbyist with the Maine Commission on Governmental Ethics and Election Practices, except for those individuals who lobby directly and solely on behalf of their employer. Additionally, those seeking a seat on the workgroup must be “able to certify applicant’s interests are not prohibitionist in nature,” according to the listed qualifications for the panel. Members chosen to serve on the working group will be selected by the OMP following the public request for applications now underway.

“Our vision as a cannabis regulator has always been to develop a good faith partnership with our stakeholders by establishing rules and policies that provide interested consumers with access to a regulated industry,” said Gundersen.

Meetings Begin Next Month

Meetings of the new medical marijuana workgroup will be conducted and chaired by representatives of the OMP at least four times between September 28 and the end of November, and recommendations of the panel will be referred to regulators and lawmakers for further action. The group will use insight from the meetings to advise regulators with the OMP on best practices in patient education and access, as well as ways to update or improve Maine’s medical cannabis program.

“Outcomes resulting from the meetings are expected to include steps that may be taken through legislation and rulemaking or developing recommendations for streamlining the office’s licensing and compliance processes to ensure the medical-use program is fulfilling the hallmarks of a regulated industry,” the OMP wrote in the release.

Applications for those wishing to serve on the Marijuana Working Group and a schedule of upcoming meetings are available online. Applications for membership on the panel will be accepted by the OMP until Friday, September 3, 2021.

The post Maine Recruiting Members of New Medical Marijuana Workgroup appeared first on High Times.

Episode 371 – Where Cannabis Reform is Headed

Mike Liszewski and Brian Adams join host Heather Sullivan to talk about the future of cannabis reform at the local level, what 2022 could hold for the reform of psychedelic laws, and the latest developments in Ohio for legalized adult use marijuana. Produced by Shea Gunther.